---
figid: PMC7359022__13045_2020_920_Fig4_HTML
figtitle: Dual role of HMGB1 in chemoresistance
organisms:
- Human immunodeficiency virus 1
- Human T-cell leukemia virus type I
- Homo sapiens
- Mus musculus
- Canis lupus familiaris
- Prevotella sp.
- Zoysia japonica
organisms_ner:
- Homo sapiens
- Mus musculus
- Canis lupus familiaris
- Drosophila melanogaster
pmcid: PMC7359022
filename: 13045_2020_920_Fig4_HTML.jpg
figlink: pmc/articles/PMC7359022/figure/Fig4/
number: F4
caption: 'The dual role of HMGB1 in chemoresistance. HMGB1-dependent autophagy promotes
  chemoresistance in three ways: nuclear HMGB1 upregulates the expression of HSP27,
  cytoplasmic HMGB1 activates the Beclin-1/PI3K-III complex, and extracellular HMGB1
  binds to RAGE. Chemotherapy also activates SIRT6/PARP1 and promotes HMGB1 acetylation
  and translocation, inducing autophagy. HMGB1 inhibits apoptosis to enhance chemoresistance
  by inhibiting the caspase3/9 pathway and inducing Bcl-2 release. In contrast, HMGB1
  induces tumor cell senescence to improve chemotherapy. HMGB1 binds to TLR2/4 and
  then activates the NF-κB signaling pathway, inducing p53-dependent cellular senescence.
  HMGB1 can also induce apoptosis-to-senescence in tumor cells'
papertitle: 'High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic
  malignancies.'
reftext: Shunling Yuan, et al. J Hematol Oncol. 2020;13:91.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9002112
figid_alias: PMC7359022__F4
figtype: Figure
redirect_from: /figures/PMC7359022__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7359022__13045_2020_920_Fig4_HTML.html
  '@type': Dataset
  description: 'The dual role of HMGB1 in chemoresistance. HMGB1-dependent autophagy
    promotes chemoresistance in three ways: nuclear HMGB1 upregulates the expression
    of HSP27, cytoplasmic HMGB1 activates the Beclin-1/PI3K-III complex, and extracellular
    HMGB1 binds to RAGE. Chemotherapy also activates SIRT6/PARP1 and promotes HMGB1
    acetylation and translocation, inducing autophagy. HMGB1 inhibits apoptosis to
    enhance chemoresistance by inhibiting the caspase3/9 pathway and inducing Bcl-2
    release. In contrast, HMGB1 induces tumor cell senescence to improve chemotherapy.
    HMGB1 binds to TLR2/4 and then activates the NF-κB signaling pathway, inducing
    p53-dependent cellular senescence. HMGB1 can also induce apoptosis-to-senescence
    in tumor cells'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HMGB1
  - AGER
  - MOK
  - TLR2
  - TLR4
  - MYD88
  - BECN1
  - TIMP1
  - FECH
  - EPX
  - OPRM1
  - MTOR
  - IRAK1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - PINK1
  - HSPB1
  - HSPB2
  - WDTC1
  - TP53
  - TP63
  - TP73
  - SIRT6
  - Hmgb1
  - Ager
  - Mok
  - Tlr2
  - Tlr4
  - Myd88
  - Timp1
  - Oprm1
  - Mtor
  - Casp9
  - Casp3
  - Irak1
  - Pik3r1
  - Akt1
  - Pink1
  - Hspb2
  - Wdtc1
  - Mdga2
  - Trp53
  - Sirt6
  - Dsp1
  - tlr-2
  - Toll-4
  - Atg6
  - Pka-R2
  - Epp
  - mor
  - Tor
  - Dronc
  - Decay
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - park
  - Hsp27
  - adp
  - p53
  - betaTub60D
  - hth
  - ADP
---
